US 9334246
Substituted triazines for malaria treatment and chemoprophylaxis
granted A61KA61K31/53A61K31/5377
Quick answer
US patent 9334246 (Substituted triazines for malaria treatment and chemoprophylaxis) held by The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research
- Grant date
- Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/53, A61K31/5377, A61K45/06, A61P